March 16, 2023 04:06 PM EDT
Pharma

SEC says Eli Lil­ly can't avoid re­quests for more in­fo on di­ver­si­ty ef­forts, abor­tion stance

Nicole DeFeudis

Editor

Eli Lil­ly must ad­dress pro­pos­als re­quest­ing re­ports on its di­ver­si­ty, eq­ui­ty and in­clu­sion progress, and its abor­tion poli­cies, the SEC de­ter­mined last week.

The news …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ver­tex’s non-opi­oid pill dis­ap­points in mid-stage chron­ic pain study

David Ep­stein gets $140M for Ot­ti­mo's bi­func­tion­al take on hot PD-1xVEGF field

Roche’s Parkin­son’s drug flunks sec­ond mid-stage tri­al

Sang­amo strikes an­oth­er brain-tar­get­ing AAV part­ner­ship, this time with Astel­las

No­var­tis turns to BioAge for new tar­gets based on longevi­ty and ex­er­cise

Ex­clu­sive: Col­or Health alums raise $10M for new start­up, us­ing AI for reg­u­la­to­ry work

A service from the Financial Times